WANY
THTX

Wealthspire Advisors (New York)’s Theratechnologies THTX Stock Holding History

Wealthspire Advisors (New York)’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,250
Closed -$121K – 3071
2025
Q2 		$121K Sell
51,250
-20,000
-28% -$49K ﹤0.01% 817
2025
Q1 		$99.8K Hold
71,250
– – ﹤0.01% 762
2024
Q4 		$129K Buy
71,250
+20,000
+39% +$27.2K ﹤0.01% 763
2024
Q3 		$63.5K Hold
51,250
– – ﹤0.01% 736
2024
Q2 		$71.8K Hold
51,250
– – ﹤0.01% 646
2024
Q1 		$85.1K Hold
51,250
– – ﹤0.01% 626
2023
Q4 		$83K Buy
+51,250
New +$77.2K ﹤0.01% 633

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $906M AUM 16.08% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Wealthspire Advisors (New York)'s THTX Position: Q3 2025 in Review

Wealthspire Advisors (New York) sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 51,250 shares — an estimated $121K sold.

Wealthspire Advisors (New York) first reported a position in THTX in Q4 2023 and held it in 7 quarters. The position peaked at $129K in Q4 2024. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Wealthspire Advisors (New York) reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 51,250 Theratechnologies shares in Q3 2025, an estimated $121K.
  • Wealthspire Advisors (New York) first reported a position in Theratechnologies in Q4 2023 and held it in 7 quarters.
  • Wealthspire Advisors (New York)'s Theratechnologies position peaked at $129K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q3 2025, filed 14 Nov 2025.